A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Recruiting	Phase 2	2026-02-11		NCT07121413

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Synvida Biotechnology Co.,Ltd.	3

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dongfang Hospital Affiliated to Tongji University	Shanghai	China	1
General Hospital of Tianjin Medical University	Tianjin	China	9
Hangzhou First People's Hospital	Hangzhou	China	8
Henan Provincial People's Hospital	Zhengzhou	China	21
Huadong Hospital Affiliated to Fudan University	Shanghai	China	6
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School	Nanjing	China	5
Shanghai Pulmonary Hospital	Shanghai	China	33
Sichuan Provincial People's Hospital	Chengdu	China	27
The Affiliated Hospital of Inner Mongolia Medical University	Neimeng	China	1
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	21
The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	20
The First Affiliated Hospital of Nanchang University	Nanchang	China	55